Cargando…
The role of adjuvant chemotherapy for patients with stage II and stage III gastric adenocarcinoma after surgery plus D2 lymph node dissection: a real-world observation
BACKGROUND: The influence of adjuvant chemotherapy on the survival of gastric adenocarcinoma patients in a stage-specific manner is controversial. METHODS: To further explore this topic, we retrospectively analyzed the impact of adjuvant chemotherapy on the clinical outcomes of 77 stage II and 117 s...
Autores principales: | Chiu, Chang-Fang, Yang, Horng-Ren, Yang, Mei-Due, Jeng, Long-Bin, Sargeant, Aaron M., Yeh, Su-Peng, Bai, Li-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909665/ https://www.ncbi.nlm.nih.gov/pubmed/27375997 http://dx.doi.org/10.1186/s40064-016-2552-3 |
Ejemplares similares
-
Lymph node staging systems in patients with gastric cancer treated with D2 resection plus adjuvant chemotherapy
por: Zhou, Yi-Xin, et al.
Publicado: (2018) -
Adjuvant Therapeutic Modalities Following Three-field Lymph Node Dissection for Stage II/III Esophageal Squamous Cell Carcinoma
por: Li, Lili, et al.
Publicado: (2017) -
Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage
por: Shin, Kabsoo, et al.
Publicado: (2019) -
The Independent Prognostic Effect of Lymph Node Dissection on Patients With Stage IA NSCLC With Different T Stages
por: Zhao, Dechang, et al.
Publicado: (2021) -
Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors
por: Mozzillo, Nicola, et al.
Publicado: (2013)